Xishuangbanna Yulin Pharmaceutical

Xishuangbanna Yulin Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and ethnic Dai medicines. Based in the Yunnan province, the company leverages local botanical resources, most notably Erigeron breviscapus (Dengzhanhua), to produce treatments for cardiovascular and cerebrovascular diseases. It is a key player in the modernization of ethnic medicine in China and operates as a wholly-owned subsidiary of China Resources Sanjiu Medical & Pharmaceutical. The company's portfolio includes various capsules, tablets, and granules distributed throughout the Chinese market, with Dengzhan Shengmai Capsules being a flagship product. Xishuangbanna Yulin is recognized for its integrated approach to the Dengzhanhua industry, spanning from cultivation to high-tech extraction and manufacturing.